Moderna To Sponsor The U.S. Open In NYC For The Second Year In A Row

They're baaaaack...and no one will care.

In vogue pharma giant Moderna will yet again sponsor the heavily attended tennis tournament in Flushing, Queens this August into September.

Sponsor signage from last year’s U.S. Open.

Last year, Moderna was anticipating the approval of their COVID-19 bivalent “vaccine” which rolled out with far less interest than the previous booster had received. In fact, Moderna’s footprint in 2022 was not a very popular one.

Lame.

Being a sponsor of the U.S. Open is essentially one big advertisement for these brands, but one has to wonder what this particular company’s return on investment is from this contract. Why does Moderna need to be positioned next to finance and luxury brands when the grant-doling U.S. government and mainstream “journalists” still give them an incredible amount of promotion at no cost at all? Are we being bombarded with Moderna to normalize risky (or, better yet, reckless) mRNA technology before the masses realize what is really happening? Is this part of an agenda that’s greater than greed in biotech?

Yawn.

Imagine having to attend two 8-hour training days for “providing accurate and helpful information about the vaccine” even though it will probably just be talking points that may or may not align with reality.

The powers that be have decided that the future is mRNA and they want you to both know that and accept it. Is it really a coincidence that informed consent went out the window at the exact same time this technology was rolled out to the world? Methinks not.